$BRBI

BRBI BR Partners S.A.

BRBI BR Partners is a Brazilian financial services company headquartered in São Paulo. It operates as one segment across four business lines: investment banking and capital markets, treasury sales and structuring, investments and wealth management, and capital remuneration. Its clients include companies, financial institutions, government agencies, institutional investors, wealthy families and individuals. BRBI provides advisory services for mergers and acquisitions, fundraising, restructuring and other strategic transactions, earning fees based on completed transactions. Its capital markets business advises on and structures debt and other securities offerings, generating underwriting, structuring and distribution fees. Treasury services include foreign exchange, derivatives and surety transactions, with income from spreads and commissions, as well as fundraising through treasury products. The company manages private investment funds and client wealth, earning management, performance and other fees, and generates returns from investments in liquid assets and reappraised assets managed by its investment operations.

1
0
1

No SEC Form 4 filings for $BRBI in the last 30 days.

See all $BRBI insider activity →

What BR Biopharma (BRBI) Said on Its Q3 Earnings Call

BR Biopharma (BRBI) reported Q3 revenue growth in Treasury Sales & Structuring (39.6% QoQ) and Wealth Management (22.1% YoY). Nine-month revenue for Treasury Sales fell 9.8% YoY. The firm reduced leverage and announced a BRL 12.6M interim dividend. CEO Rabello expects Wealth Management to become a more significant revenue contributor. BRBI operates as an investment bank in Brazil.

BRBI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BRBI (BRBI BR Partners S.A.). Coverage has been balanced: 1 bullish, 0 neutral, and 1 bearish.

What's driving BRBI

AlphAI scores every news story that mentions BRBI with an AI model for sentiment and relevance, and aggregates insider trades from BRBI BR Partners S.A.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BRBI

Score

What BR Biopharma (BRBI) Said on Its Q3 Earnings Call

BR Biopharma (BRBI) reported Q3 revenue growth in Treasury Sales & Structuring (39.6% QoQ) and Wealth Management (22.1% YoY). Nine-month revenue for Treasury Sales fell 9.8% YoY. The firm reduced leverage and announced a BRL 12.6M interim dividend. CEO Rabello expects Wealth Management to become a more significant revenue contributor. BRBI operates as an investment bank in Brazil.

Related tickers